Detection and treatment of early stage prostate cancer. Seminar. USA, 1993/12.
Few would challenge the important health burden associated with prostate cancer.
This concern, combined with the emergence of a biochemical test that has the potential for early detection, has fueled enthusiasm for concerted efforts aimed at early detection and treatment of prostate cancer.
Reflecting the approach and perspective of the Canadian Task Force on the Periodic Health Examination, this report argues for the objective evaluation of evidence to address the question of whether to initiate and promote early detection campaigns for prostate cancer.
Specifically, 3 questions are addressed : « what is the goal of early detection ? », « how should the existing evidence be evaluated ? » and « how should evidence guide our actions and policies ? ».
Mots-clés Pascal : Epithélioma, Prostate, Stade précoce, Canada, Amérique du Nord, Amérique, Dépistage, Diagnostic, Homme, Mâle, Appareil urinaire pathologie, Prostate pathologie, Appareil génital mâle pathologie, Tumeur maligne
Mots-clés Pascal anglais : Carcinoma, Prostate, Early stage, Canada, North America, America, Medical screening, Diagnosis, Human, Male, Urinary system disease, Prostate disease, Male genital diseases, Malignant tumor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0217757
Code Inist : 002B14D02. Création : 09/06/1995.